Embattled Drug Discount Dispute Process Gets HHS Facelift (2)

The drug industry and health providers are divided over a freshly revised review process for resolving price fights after years of back-and-forth between presidential administrations and federal courts.

The Health and Human Services Department on Thursday announced a final rule (RIN 0906-AB28) that updates the administrative dispute resolution process for drugmakers and health providers participating in the federal 340B drug discount program.

Under the program, drugmakers are required to discount their products to covered medical providers such as hospitals, community health centers, and others supporting low-income populations.

The HHS positioned its effort as a way to make the 340B dispute ...